Patients' Breast Radiotherapy Experiences Beat Expectations

This article originally appeared here.
Share this content:
Patients' Breast Radiotherapy Experiences Beat Expectations
Patients' Breast Radiotherapy Experiences Beat Expectations

WEDNESDAY, Feb. 28, 2018 (HealthDay News) -- Most patients report having little to no knowledge about breast radiotherapy (RT), and patients' experiences are generally better than their expectations, according to a study published online Feb. 26 in Cancer.

Narek Shaverdian, M.D., from the University of California at Los Angeles, and colleagues surveyed patients who were free of disease recurrence and had been treated between 2012 and 2016 regarding their perceptions of their RT experience. Five hundred two patients were surveyed, and 327 responded; about 83 percent of the patients underwent breast conservation therapy.

The researchers found that about 68 percent of patients endorsed that they initially had little to no knowledge regarding RT; about 47 percent reported having heard frightening stories. Only about 2 percent of patients agreed that the negative stories they had heard about RT were true. Most patients treated with breast conservation (about 92 percent) and mastectomy (81 percent) agreed that "if future patients knew the real truth about RT, they would be less scared about treatment." The overall severity of short-term and long-term effects was reported to be better than or as expected by 83 and 84 percent of patients, respectively.

"Breast RT is associated with misconceptions and fears," the authors write. "Patients' experiences with modern breast RT appear to be superior to expectations, and the majority of patients in the current study agreed that their initial negative impressions were unfounded."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »